The Gibson group engages in computational genomics related to human genetics. A major current focus is the use of transcriptomics for personalized medicine, from predicting the course of complicated inflammatory bowel disease, to diagnosing the molecular basis of congenital diseases. We are also interested in the evolution of complex disease risk and the philosophy of therapeutic intervention.
Profile